SCHEMBL6283329

SCHEMBL6283329

Nc1c(-c2ccccc2)nn2[nH]nnc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 3/20 0.39
HSD17B10 Q99714 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 2/20 0.39
GAA P10253 2/20 0.39
RAB9A P51151 2/20 0.39
GLA P06280 2/20 0.38
LMNA P02545 1/20 0.38
ADORA1 P30542 3/20 0.37
ADORA2A P29274 2/20 0.37
CLK4 Q9HAZ1 3/20 0.36
CSNK1A1 P48729 2/20 0.36
CSF1R P07333 2/20 0.36
KDR P35968 2/20 0.36
GSK3A P49840 2/20 0.36
GSK3B P49841 2/20 0.36
CDK5 Q00535 2/20 0.36
RPS6KA5 O75582 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6288027 0.71 KMT2A (0.40) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL6287250 0.68 KDM4E (0.44) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL6288034 0.68 ALDH1A1 (0.40) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL6282852 0.67 ALDH1A1 (0.36) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL6286160 0.66 KDM4E (0.36) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL4913392 0.63 ALDH1A1 (0.45) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL6283324 0.63 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL2271734 0.63 CGAS (0.47) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL33804 0.62 MAPT (0.55) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL4914514 0.62 ALDH1A1 (0.44) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923929-B1 KERATIN FIBRE DYE COMPOSITION CONTAINING PYRAZOLO-AZOLE COMPOUNDS, USE THEREOF AS OXIDATION AGENTS, AND DYEING METHOD; PYRAZOLOAZOLES OREAL (FR) 2004-05-12 EP claimed
US-20020152558-A1 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles L'OREAL 2002-10-24 US claimed
US-6379397-B2 CAPABLE OF GENERATING INTENSE COLORINGS IN VARIED SHADES L'OREAL S.A. (FR) 2002-04-30 US claimed
US-6855827-B2 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles L'ORÉAL (FR) 2005-02-15 US disclosed
US-20020152558-A1 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles L'OREAL 2002-10-24 US disclosed
US-6379397-B2 CAPABLE OF GENERATING INTENSE COLORINGS IN VARIED SHADES L'OREAL S.A. (FR) 2002-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020152558-A1 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles KRT18, ZYX, TUBB3 KDM4E 1907/4885ALDH1A1 264/4885HPGD 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.